11/17/2021, 12:24 PM (Source: TeleTrader)
more TeleTrader news

US to buy more GSK doses for $651M - report

The United States government has signed a contract for a further 300,000 doses of GlaxoSmithKline's (GSK) sotrovimab COVID-19 antibody drug, according to a source quoted by the Wall Street Journal on Wednesday.

The deal is reportedly worth $651 million and brings the total order value close to $1 billion, following an initial order worth $280 million.

Sotrovimab, co-developed by GSK with Vir Biotechnology Inc, received authorization for emergency use by the Food and Drug Administration (FDA) in May.

Baha Breaking News (BBN) / IB